| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 54, 725-732, Copyright © 1982 by Endocrine Society
ARTICLES |
J Aiman and JE Griffin
To ascertain the frequency of androgen resistance as the cause of male infertility and to determine whether endocrine abnormalities are a universal feature of the disorder, we measured the androgen receptor in fibroblasts cultured from the genital skin of 28 unrelated phenotypically normal men with idiopathic azoospermia or oligospermia. The amounts of androgen receptor were compared with those in genital skin fibroblasts from a variety of other subjects, including 10 men with azoospermia of known cause, 5 normal men, 28 subjects with disorders of androgen formation of metabolism of known cause, and 28 persons with documented disorders of the androgen receptor (testicular feminization and Reifenstein syndrome). The mean androgen receptor Bmax (amount of high affinity binding) was 12 fmol/mg protein or greater in 10 infertile men with azoospermia of known cause and in 6 infertile men with mild oligospermia. In fibroblasts from 1 to 4 individuals with severe oligospermia of unknown cause (less than 1 million/ml) and 8 of 18 subjects with idiopathic azoospermia, the androgen receptor Bmax was less than 12 fmol/mg protein. The mean value in these 9 men was not significantly different from that in subjects with testicular feminization or Reifenstein syndrome. Serum concentrations of testosterone and LH were normal in 6 of these 9 infertile men, and plasma production rates of testosterone were elevated in only 2 of the 6 men studied in whom the Bmax values in genital skin fibroblasts were less than 12 fmol/mg protein. We conclude that androgen resistance may be the cause of a significant fraction (40% or more) or idiopathic male infertility due to azoospermia or severe oligospermia, and that this disorder may not be manifested by a functional defect in the pituitary- testicular axis.
This article has been cited by other articles:
![]() |
C. A. Davis-Dao, E. D. Tuazon, R. Z. Sokol, and V. K. Cortessis Male Infertility and Variation in CAG Repeat Length in the Androgen Receptor Gene: A Meta-analysis J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4319 - 4326. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Suzuki, I. Sasagawa, T. Tateno, J. Ashida, T. Nakada, K. Muroya, and T. Ogata Mutation screening and CAG repeat length analysis of the androgen receptor gene in Klinefelter's syndrome patients with and without spermatogenesis Hum. Reprod., August 1, 2001; 16(8): 1653 - 1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Hiort, P.-M. Holterhus, T. Horter, W. Schulze, B. Kremke, M. Bals-Pratsch, G. H. G. Sinnecker, and K. Kruse Significance of Mutations in the Androgen Receptor Gene in Males with Idiopathic Infertility J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2810 - 2815. [Abstract] [Full Text] |
||||
![]() |
S. Dadze, C. Wieland, S. Jakubiczka, K. Funke, E. Schroder, B. Royer-Pokora, R. Willers, and P.F. Wieacker The size of the CAG repeat in exon 1 of the androgen receptor gene shows no significant relationship to impaired spermatogenesis in an infertile Caucasoid sample of German origin Mol. Hum. Reprod., March 1, 2000; 6(3): 207 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.J. Ghadessy, S.L. Liow, and E.L. Yong Mutations in the promoter region of the androgen receptor gene are not common in males with idiopathic infertility Mol. Hum. Reprod., March 1, 1999; 5(3): 287 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Komori, H. Kasumi, R.-i. Kanazawa, K. Sakata, Y. Nakata, H. Kato, and K. Koyama CAG repeat length in the androgen receptor gene of infertile Japanese males with oligozoospermia Mol. Hum. Reprod., January 1, 1999; 5(1): 14 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wang, F. J. Ghadessy, A. Trounson, D. de Kretser, R. McLachlan, s. C. Ng, and E. L. Yong Azoospermia Associated with a Mutation in the Ligand-Binding Domain of an Androgen Receptor Displaying Normal Ligand Binding, but Defective Trans-Activation J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4303 - 4309. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |